UTAH MEDICAL PRODUCTS INC (UTMD) Stock Price, Quote, News and Overview
NASDAQ:UTMD - Nasdaq - US9174881089 - Common Stock - Currency: USD
UTMD Quote, Performance and Key Statistics
52.37
-0.5 (-0.95%)
The current stock price of UTMD is 52.37 USD. In the past month the price decreased by -6.79%. In the past year, price decreased by -19.8%.
UTMD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 31.13 | 47.44B | ||
| COO | COOPER COS INC/THE | 21.46 | 16.18B | ||
| ALGN | ALIGN TECHNOLOGY INC | 19.63 | 13.42B | ||
| SOLV | SOLVENTUM CORP | 9.88 | 11.43B | ||
| LNTH | LANTHEUS HOLDINGS INC | 15.01 | 6.97B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 26.5 | 5.59B | ||
| BLCO | BAUSCH + LOMB CORP | 22.15 | 4.85B | ||
| ICUI | ICU MEDICAL INC | 21.81 | 3.34B | ||
| HAE | HAEMONETICS CORP/MASS | 14.78 | 3.14B | ||
| XRAY | DENTSPLY SIRONA INC | 8.23 | 2.74B | ||
| UFPT | UFP TECHNOLOGIES INC | 27.21 | 1.59B | ||
| NEOG | NEOGEN CORP | 13.58 | 1.12B |
Related stock screener links
About UTMD
Company Profile
Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 155 full-time employees. The firm markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
Company Info
UTAH MEDICAL PRODUCTS INC
7043 S 300 West
Midvale UTAH 84047 US
CEO: Kevin L. Cornwell
Employees: 180
Company Website: http://www.utahmed.com
Investor Relations: http://www.utahmed.com/investor-relations.html
Phone: 18015661200
UTAH MEDICAL PRODUCTS INC / UTMD FAQ
What is the stock price of UTAH MEDICAL PRODUCTS INC today?
The current stock price of UTMD is 52.37 USD. The price decreased by -0.95% in the last trading session.
What is the ticker symbol for UTAH MEDICAL PRODUCTS INC stock?
The exchange symbol of UTAH MEDICAL PRODUCTS INC is UTMD and it is listed on the Nasdaq exchange.
On which exchange is UTMD stock listed?
UTMD stock is listed on the Nasdaq exchange.
What is UTAH MEDICAL PRODUCTS INC worth?
UTAH MEDICAL PRODUCTS INC (UTMD) has a market capitalization of 171.77M USD. This makes UTMD a Micro Cap stock.
How many employees does UTAH MEDICAL PRODUCTS INC have?
UTAH MEDICAL PRODUCTS INC (UTMD) currently has 180 employees.
What are the support and resistance levels for UTAH MEDICAL PRODUCTS INC (UTMD) stock?
UTAH MEDICAL PRODUCTS INC (UTMD) has a support level at 52.29 and a resistance level at 52.88. Check the full technical report for a detailed analysis of UTMD support and resistance levels.
Should I buy UTAH MEDICAL PRODUCTS INC (UTMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of UTMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of UTMD, evaluating the profitability, health, valuation and growth aspects
- UTAH MEDICAL PRODUCTS INC (UTMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- UTAH MEDICAL PRODUCTS INC (UTMD) Sales and EPS estimates to see what analysts future expectations are.
- UTAH MEDICAL PRODUCTS INC (UTMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- UTAH MEDICAL PRODUCTS INC (UTMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- UTAH MEDICAL PRODUCTS INC (UTMD) Stock Chart to make your own analysis
- UTAH MEDICAL PRODUCTS INC (UTMD) Latest news and press-releases to stay up to date.
Does UTAH MEDICAL PRODUCTS INC (UTMD) stock pay dividends?
UTAH MEDICAL PRODUCTS INC (UTMD) has a dividend yield of 2.29%. The yearly dividend amount is currently 1.22. Check the full fundamental report for a detailed analysis of UTMD dividend history, reliability and sustainability.
When does UTAH MEDICAL PRODUCTS INC (UTMD) report earnings?
UTAH MEDICAL PRODUCTS INC (UTMD) will report earnings on 2025-07-23.
What is the Price/Earnings (PE) ratio of UTAH MEDICAL PRODUCTS INC (UTMD)?
The PE ratio for UTAH MEDICAL PRODUCTS INC (UTMD) is 13.26. This is based on the reported non-GAAP earnings per share of 3.95 and the current share price of 52.37 USD. Check the full fundamental report for a full analysis of the valuation metrics for UTMD.
What is the Short Interest ratio of UTAH MEDICAL PRODUCTS INC (UTMD) stock?
The outstanding short interest for UTAH MEDICAL PRODUCTS INC (UTMD) is 2.35% of its float. Check the ownership tab for more information on the UTMD short interest.
UTMD Technical Analysis
UTMD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to UTMD. UTMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
UTMD Financial Highlights
Over the last trailing twelve months UTMD reported a non-GAAP Earnings per Share(EPS) of 3.95. The EPS decreased by -13.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 33.92% | ||
| ROA | 11.32% | ||
| ROE | 11.81% | ||
| Debt/Equity | 0 |